Systemic fungal infections in renal diseases

Journal of Postgraduate Medicine

Volumn 51, Issue 5, 2005, Pages

  Gandhi, B V ^a   Bahadur, M M ^a   Dodeja, H ^a   Aggrwal, V ^a   Thamba, A ^a   Mali, M ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Liposomal Amphotericin B; Renal disease; Systemic fungal infections

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CASPOFUNGIN; CLOTRIMAZOLE; DEFEROXAMINE; FLUCONAZOLE; FLUCYTOSINE; FUNGISOME; GLUCOCORTICOID; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; PYRROLE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ALUMINUM OVERLOAD; ANEMIA; ARTHRALGIA; ASPERGILLOSIS; BONE MARROW DEPRESSION; CANDIDIASIS; CHILL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CRYPTOCOCCOSIS; DIALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE CALCULATION; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG EXCRETION; DRUG FEVER; DRUG HALF LIFE; DRUG MARKETING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TISSUE LEVEL; DRUG TOLERABILITY; EXUDATE; GRAFT RECIPIENT; HEMODIALYSIS; HISTOPLASMOSIS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IRON OVERLOAD; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY GRAFT; LIVER LEVEL; MORBIDITY; MUCORMYCOSIS; MYALGIA; MYCOSIS; NAUSEA; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PAIN; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONITIS; PNEUMOCYSTOSIS; POSTOPERATIVE PERIOD; REVIEW; SIDE EFFECT; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING;

ANTIFUNGAL AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MYCOSES;

EID: 33645554234     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. th edn. Philadelphia: Lippincott Williams and Wilkins; 2000.
2. Weissgarten J, Modai D, et al. Induction of suppressor cells in normal lymphocytes by uremic serum. Into Arch Allergy Apple Immnol 1986;81:180.
3. June- Mug sung, et al. Candidaemia in patients with dialysis dependent ARF etiology, predisposing and prognostic factors. NDT 2001;16:2348-56.
4. Rex JH, Bennette TG. Candidaemia study group and the national institute of Allegy and infectious disease mycoses study group. A randomized trial company Fluconazole with Ampho B for treatment of candidaemia in patients without neutropenia. NETM 1994;331:1325-30.
5. Talwerker NC, Acharya VN, Sheth SM, Rhinocerebral mucormycosis in a case of renal failure. JPGM 1981;27:190-3.
6. Weath H, Margensen P. Extracorporeal shock wave lithotripsy of a kidney stone complicated with candida albicans septicemia and endophthalmitis: case report. Scand J Urol Nephrol 1990;24:81
7. Raghavan R, Date A, Bhaktivijayan A. Fungal and nocardial infections of the kidney. Histopathology 1987;11:9-20
8. Abott KC, Hypolite I. Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron 2001;89:426-32.
9. Van Cutsem J, Boleacrt JR. Effects of desferoxamine and iron on experimental mucormycosis, KI 1980;36:1061.
10. Nagappan R, Collins JF, Lee WT. Fungal Peritonitis in CARD: the Auckland experience. Am J Kidney Dis 1992;20:490-2.
11. Ping - Nam wong. A retrospective study of 7 cases of candida peritonitis in CAPD patients. The therapeutic options. Peritoneal Dialysis International 2000;20:76-9.
12. Prasad KN, Prasad N, Gupta A. Fungal peritonitis in patients on CAPD, a single center India experience. J Infect 2004;48:703.
13. Montane BS, et al. Fungal peritonitis in Pediatric patients. Adv Perit Dial 1998;14:251-4
14. Kease WF, et al. Peritoneal Dialysis related peritonitis: treatment recommendation. 1996;16:551
15. Keane WF, Baile GR, et al. ISPD guidelines/recommendations. Adult peritoneal dialysis-related peritonitis recommendations. update. Perit Dial Int 2000;20:396-411.
16. George IIJ, V. Shankar. Epidemiology of systemic mycoses among renal transplant recipients in India. Transplantation 2003;75:1544-51.
17. rd world countries, NDT. 1993;8:168.
18. Peterson PK, Ferguson R, et al. Infectious diseases in hospitalized renal transplant recipients: a prospective study of complex and evolving problem. Medicine 1982;61:360.
19. Abott KC, Hypolite I, et al. Hospitalisation for fungal infections after renal transplant in the United States. Transplant Infect Dis 2001;3:203-11.
20. Gupta KL. Fungal infections and the kidney. Indian J Nephrol 2001;11:147-54.
21. Luke RG, Boyle JA. Renal effects of Amphotericin B lipid complex. Am J Kidney Dis 1998;31:780-5.
22. Bodhe PV, Kotwani RN, Kirodian BG, Kshirsagar, Pandya SK. Open label, Randomized, comparative Phase Iii safety and efficacy study with conventional Amphotericin B and Liposomal Amphotericin B in patients with systemic Fungal infections. JAPI 2002;50:662-70.
23. Gokhale PC, Barapatre RJ, Advani SH, Kshirsagar NA, Pandya SK Pharmacokinetic and tolerance of Liposomal Amphotericin B in patients. Jr Antimicrob Chem 1993;32:133-9.
24. Lucile Cousin, Marie Le Berre, Vincent Launay-Vacher, Hassane Izzedine, Gilbert Deray. Dosing guidelines for fluconazole in patients with renal failure. Nephrol Dial Transplant 2003;18:2227-31.